Mechanisms of the epithelial-mesenchymal transition by TGF-beta - Test2 - elhamkhani - TriplyDB

Mechanisms of the epithelial-mesenchymal transition by TGF-beta

Mechanisms of the epithelial-mesenchymal transition by TGF-beta

http://www.wikidata.org/entity/Q33804105

about

Role of DeltaNp63gamma in epithelial to mesenchymal transition EMT in Breast Carcinoma-A Review Neuropilins: expression and roles in the epithelium The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United States EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer.VEGF ameliorates tubulointerstitial fibrosis in unilateral ureteral obstruction mice via inhibition of epithelial-mesenchymal transition TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion.STAT3 and epithelial-mesenchymal transitions in carcinomas Two faces of TGF-beta1 in breast cancer.Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes.Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cells Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling.Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.Unmasking epithelial-mesenchymal transition in a breast cancer primary culture: a study report The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)Inhibition of TGF-β signaling enables human corneal endothelial cell expansion in vitro for use in regenerative medicine Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.The role of cytokines in breast cancer development and progression Signaling pathways in renal cell carcinoma.Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling.Activation of platelet protease-activated receptor-1 induces epithelial-mesenchymal transition and chemotaxis of colon cancer cell line SW620.The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells TGFβ Pathway Inhibition Redifferentiates Human Pancreatic Islet β Cells Expanded In Vitro Antimetastatic effect of fluvastatin on breast and hepatocellular carcinoma cells in relation to SGK1 and NDRG1 genes.Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells.The molecular biology of brain metastasis Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3 Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts.Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.

P2860

Q24632945-27794FB5-44F8-4C02-A01E-504F50A0DF8F Q26739625-36C6AB6D-717D-4CA8-9073-CA440900DB80 Q26998786-0A5DDCC3-5997-4A56-950A-E14DA096FE61 Q28388257-422A3991-7551-4382-9011-B88AD1A04BBF Q28477031-73307F46-13E8-4FF6-81F9-7EDB4509EDDA Q28487676-A4A41850-0226-4BF3-8A23-3C035814B68D Q29616360-6BB12483-82E8-4824-A723-868833139350 Q30502431-FDF55EBE-1E39-4E13-B45E-B884F7DEA198 Q33566806-64E7FDF6-0208-4DAF-BD6B-59AB9D98627E Q33598619-A58463EB-42DC-4001-B2A5-4AB6208562B8 Q33623947-80468B94-D7BC-4125-B701-A18E65B4D83A Q33661529-29908A60-118F-4FDE-991E-3F2C1C2FCF1A Q33705247-35BBB563-A5FE-4DB1-AB12-667A717E9FA4 Q33739802-12B875FB-97DC-42CC-898D-CB8E2234D8C8 Q33857806-02A9B06F-F800-46DD-ACFB-099F8F6F08D9 Q33865464-DE264F18-BEA1-43CF-91A7-E7FC5C7A7FBF Q33902576-78425388-3E21-44E9-AF70-ABCBA29E2739 Q34163525-9C01B058-7A7C-488A-8B6D-441499DE90CF Q34324979-B83C0328-E786-425A-8BFF-E67716824376 Q34397165-BDFB9B49-E1BF-4052-8409-16D1B2A971EB Q34397291-4E4EC1F4-7BF2-441C-8740-60DE3ED591DD Q34529319-7B49DCC1-1912-44DF-B55E-880AA97B123F Q34603960-11A6752F-559A-4FD3-BF81-7C372F224492 Q34789337-F2AE3D38-9A54-4808-A823-8CB52E3BC5D6 Q34887552-CF6EEB97-E1F3-49C2-A524-EF6B6759E3F9 Q34920381-EE2DE455-3F4F-41BA-A529-0D162419D412 Q34978827-3E57AE22-B699-4593-89DA-16B0C894A1DD Q35490960-665A2754-014B-448A-BC9C-6D3913A51318 Q35589700-4E0D45E6-FEE8-47DE-972B-741DC4364B33 Q35605751-398963BB-5F90-41D9-8094-8296276ED135 Q35633302-771C822C-AD24-41BF-BF3D-74596CB4E7E9 Q35791836-4E62DD8B-6C3B-47D3-A22E-D104AD02D8E2 Q35792358-A6A79A0B-D572-4318-A6CE-0543A9FE7BFE Q35800555-E8AA3304-8FF8-4BDE-B572-61F30F86F536 Q35864968-18E77490-3B47-4F8E-BF3B-D2B4D8270CCD Q35914358-8FB3BA36-0B61-4940-A7ED-42A0BDDB9860 Q35918076-532D851E-7D07-4A51-B96C-3AB950FFF6EE Q36044923-25644CA6-D1FB-41E0-8862-EAE58BE00525 Q36164879-BCE9160F-F6B8-496E-8DA8-0D9FC4AC8CAE Q36261743-308E36BD-22E9-48A8-A670-68B071D76BE5

P2860

Mechanisms of the epithelial-mesenchymal transition by TGF-beta

http://www.wikidata.org/entity/Q33804105

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Mechanisms of the epithelial-mesenchymal transition by TGF-beta

@ast

Mechanisms of the epithelial-mesenchymal transition by TGF-beta

@en

type

label

Mechanisms of the epithelial-mesenchymal transition by TGF-beta

@ast

Mechanisms of the epithelial-mesenchymal transition by TGF-beta

@en

prefLabel

Mechanisms of the epithelial-mesenchymal transition by TGF-beta

@ast

Mechanisms of the epithelial-mesenchymal transition by TGF-beta

@en

P1433

Q33804105-29808652-AEA0-4EA1-B052-0C7D313E460B

P1476

Q33804105-5FDBD284-C86C-40D3-B82F-2A90DDBA7AB7

P2093

Q33804105-0CBAA8AE-2F86-4009-A580-873BFE1BD266

Q33804105-E3CB93FB-3847-4AE0-8DB2-FEECCB562B76

Q33804105-FA4C4997-CFDC-452B-A292-6732CADF8397

P2860

Q33804105-01DD6C8D-F8D3-4298-A550-829216B71852

Q33804105-02192D59-16E3-48D3-B8DF-13C5F212D01A

Q33804105-02E9C315-0E8C-4050-A5BD-C601D5F173B4

Q33804105-03BE4851-C808-417E-95A6-07CEF0317A7B

Q33804105-04212CEB-2668-4AAC-B237-80FBACFF3E1E

Q33804105-05BF1960-8F1B-475F-AEDF-69592876AF6C

Q33804105-062A2B4F-053C-407C-B24F-2D01589141AC

Q33804105-0A6AAF86-04CF-4616-9983-5040BB022351

Q33804105-0B25FF75-1834-4A4A-A35F-3403A0F1722D

Q33804105-0C226A05-275C-4859-881F-0215F797B783

P304

Q33804105-41DCB1C8-60D2-402F-A533-F66B15D7FE5A

P31

Q33804105-2B18C969-76AF-49D9-98D9-F49FBA4C2799

P356

Q33804105-DD5A19AB-F35E-43C2-A707-265D9A7B23C1

P407

Q33804105-A0DBF0E4-9216-4BC6-A331-72CEE746A00C

P433

Q33804105-8AF90C3A-F6BC-4955-BE2D-C68705C50A73

P478

Q33804105-223B41F8-7138-4F3A-B289-2EB918CBA574

P577

Q33804105-6CCB4E51-845F-4926-9BBA-548FE25D999B

P5875

Q33804105-C42FBD04-4BB6-43D3-A5E1-90D13DDA651F

P698

Q33804105-56E483A4-8272-4F5C-B410-C9761B398CE4

P932

Q33804105-B78EAAA4-337A-4C72-9A00-B5D923902E15

P356

P1433

Future Oncology

P1476

Mechanisms of the epithelial-mesenchymal transition by TGF-beta

@en

P2093

Michael K Wendt

http://www.w3.org/2001/XMLSchema#string

Tressa M Allington

http://www.w3.org/2001/XMLSchema#string

William P Schiemann

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor beta signaling

SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor

Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate

The Hallmarks of Cancer

Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation

Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation

The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway.

TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation

Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT)

Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity

P304

1145-1168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.09.90

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38032203

http://www.w3.org/2001/XMLSchema#string

P698

19852727

http://www.w3.org/2001/XMLSchema#string

P932

2858056

http://www.w3.org/2001/XMLSchema#string